HIV and AIDS Research Journal.

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Market Analysis, Hiv Aids Res J Vol: 2 Issue: 2

Market Analysis on HIV, STD & STI

Ahmed G. Hegazi

Professor of Microbiology and Immunology National Research Center, Dokki, Giza, Egypt E-mail: [email protected]

Keywords: HIV and AIDS

About HIV, STD & STI

We take the pride to welcome you to the “3rd International Conference on HIV, STD & STI” to be conducted on April 22-23, 2020 at Singapore Town, Singapore. Theme of the conference is “Aiming for a HIV free society”. HIV 2020 conference gathers noted Eminent Scientists/Research Professors, Junior/Senior analysis fellows, Students, Doctors also researchers from World Health Societies & Associations and Medical Universities under one roof where networking and world partnering happens for the acceleration of future research.`

Why to attend HIV 2020:

HIV 2020 Conference is composed of many intriguing educational programs along with multiple panels, workshops, affinity cluster lunches, paper displays, and scientific sessions by professionals. Everybody being a part of this conference gets certification for his/her participation and a platform to reconstruct client base. We arrange to offer all delegates and great professors with all potential basic amenities and for attendees a source of information concerning all the upcoming technologies lined up.

Importance and Scope

Theme of the conference “Aiming for a HIV Free Society” conveys the essential notion that we tend to showcase to the planet. HIV 2020 prioritizes the high quality researches and technologies used for human health, welfare and convenience. Folks from each genre i.e. the extremely classified professionals, scientists, researchers and young innovators have an excellent deal during this as they will be having an opportunity for diversification and world communication. We tend to believe HIV 2020 can start up as a seminar study and a platform jam-packed with public awareness.

Business worth of HIV:

In June 1981, scientists reported the first clinical evidence of a disease known as acquired immunodeficiency syndrome, or AIDS. Its cause, the human immunodeficiency virus (HIV), was acknowledged in 1983. Since the start of the epidemic in 1981, around 75 million have become infected with HIV and around 32 million people have died of AIDS-related illnesses. In 2018, there were 37.9 million people living with HIV.

New HIV infections have fallen by 16% since 2010 (by 41% among children) and AIDS-related deaths have fallen by 55% since the peak in 2004. The United Nation family has been in the forefront of this improvement. Ending AIDS by 2030 is an integral part of the Sustainable Development Goals (SDGs), which were unanimously adopted by United Nations Member States in 2015.

HIV Treatment Access: in 2018, 23.3 million folks with HIV (62%) were accessing antiretroviral medical care (ART) globally, a rise of one.6 million since 2017 and up from eight million in 2010.

Mother-to-Child Transmission: In 2018, ninety two of pregnant ladies with HIV received ART to stop transmission HIV to their babies throughout physiological state and childbearing and to shield their own health. This is often compared to forty ninth in 2010.

AIDS-related Deaths: AIDS-related deaths are reduced by over fifty fifth since the height in 2004. In 2018, around 770,000 folk sided from AIDS-related diseases worldwide, compared to one.2 million in a pair of010 and one.7 million in 2004.

Regional Impact: the overwhelming majority of individuals with HIV are in low- and middle-income countries. In 2018, there have been twenty.6 million folks with HIV (57%) in Japanese and southern continent, 5.0 million (13%) in western and Central African Republic, 5.9 million (16%) in Asia and therefore the Pacific, and 2.2 million (6%) in Western and Central Europe and North America.

Funding for HIV

To finish AIDS as a public health threat by 2030, UNAIDS estimates that US$26.2 billion are going to be needed for the world HIV response in two020 alone. This implies the planet should increase the number of resources out there for HIV by US$1.5 billion every year between 2016 and 2020, a scenario that's wanting more and more unlikely.

In recent years, high-income countries have reduced funding for the HIV response in low- and middle-income countries, with a seven-membered decrease according between 2015 and 2016. Philanthropic donations, on the opposite hand, have up for the past 3 consecutive years.

Universities related to HIV/AIDS Worldwide:

USA:

Augusta University

Wayne State University

Penn University

University of Maryland

Drexel University

University Of Miami

University of Georgia

Harvard University

Washington University

University of Illinois

University of Minnesota

University of Charleston

West Virginia University

Europe:

University of Cambridge

University of Oxford

University of Copenhagen

University College London

Swiss Federal Institute of Technology Zurich

Imperial College London

University of Zurich

Karolinska Institute

University of Manchester

University of Munich

University of Edinburgh

Pierre and Marie Curie University

Catholic University of Leuven

Heidelberg University

University of Helsinki

Asia Pacific:

Osaka University

University of Tokyo

National University of Singapore

Kyoto University

Mahidol University

Tel Aviv University

University of Hong Kong

Keio University

Hebrew University of Jerusalem

Seoul National University

National Taiwan University

Sun Yat-sen University

Fudan University

Zhejiang University

Peking University

Middle East:

Alexandria University

Cairo University

American University of Kuwait

The Lebanese American University (LAU)

Weill Cornell Medical College in Qatar

Paris-Sorbonne University Abu Dhabi

Mohammed bin Rashid University of Medicine and Health Sciences

Hebrew University

King Saud bin Abdulaziz University for Health Sciences

King Saud University

Gulf Medical University

Sana'a University

HIV Related Association & Societies:

USA:

American Academy of HIV Medicine

American Sexual Health Association

Association of Nurses in AIDS Care

Association for Professionals in Infection Control and Epidemiology

International AIDS Society – USA

International AIDS Society

Infectious Diseases Society of America

British HIV Association

Australasian Society for HIV Medicine

HIV Medicine Association

International Association of Physicians in AIDS Care

National Medical Association

HIV Medicine Association

Europe:

The European AIDS Clinical Society

Aids Hilfe Wien Austria

EATG (European AIDS Treatment Group) Belgium

Czech AIDS Help Society Czech Republic

AIDS Fondnet Denmark

Deutche AIDS-Hilfe / AIDS Action Europe Germany

Global Network of People Living with HIV Netherlands

ARAS - Romanian Association against AIDS Romania

Alliance Global Ukraine

European AIDS Treatment Group

HIV Pharmacy Association

Asia Pacific:

CARAM Asia

National AIDS Programme

National Center for HIV/AIDS, Dermatology and STDs

AIDS Concern

Hong Kong AIDS Foundation

The Society for AIDS Care

HIV Medicine Association of India

AIDS Clinical Center

Korean HIV/AIDS Prevention and Support Center

Taiwan Tongzhi Hotline Association

Middle East:

Egyptian AIDS Society

Egyptian Network of NGOs fighting AIDS

AIDS Research Center of Iran

HATAM - HIV/AIDS Treatment and Research Center

Pozitif Yasam Dernegi (Positive Living Association)

Saudi Charity Association for AIDS Patients

National AIDS Programme

Israel AIDS task force

National HIV/AIDS program

Funding bodies:

Centres for Disease Control (CDC)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Child Health and Human Development (NICHD)

NIH Office of AIDS Research (OAR)

Irish Aid

Elton john AIDS foundation Mac AIDS fund The global fund

The Road Ahead:

HIV market can see modest growth to $22.5 billion by 2025.

The human immunological disorder virus (HIV) market across the 9 major countries of the USA, France, Germany, Italy, Spain, the UK, Japan, Brazil, and China, is about to grow from $16.3 billion in 2015 to $22.5 billion by 2025, representing a compound annual rate of simply over threedimensional, in step with Global Data, a recognized leader in providing business info and analytics.

Conclusion:

HIV 2020 through this learning experience dreams for a society where HIV infections are rare and when they do follow, all person, irrespective of age, gender, race/ethnicity, sexual orientation, gender identity or socioeconomic circumstance, will have unrestricted access to high quality, life-extending care, free from disgrace and
discrimination.

References:

1. https://www.who.int/gho/hiv/en/
2. https://www.avert.org/professionals/hivaround-world/global-response/funding

Track Your Manuscript

Recommended Conferences

Share This Page